CIP2A and ovarian serous cystadenocarcinoma: Considering the contribution of CIP2A in the process of tumorigenesis in different cancers, we have also determined the alterations (Amplification and Gain) of KIAA1524 gene in Lung Squamous Cell Carcinoma (TCGA, Provisional), Ovarian Serous Cystadenocarcinoma (TCGA, Provisional), and Head & Neck Squamous Cell Carcinoma (TCGA, Provisional) using c-bioPortal (Figure 4).